Richard S. Eiswirth Jr.
Net Worth

Last updated:

What is Richard S. Eiswirth Jr. net worth?

The estimated net worth of Mr. Richard S. Eiswirth Jr. is at least $9,729,226 as of 15 Dec 2021. He has earned $273,676 from insider trading and has received compensation worth at least $9,455,550 in Alimera Sciences, Inc..

What is the salary of Richard S. Eiswirth Jr.?

Mr. Richard S. Eiswirth Jr. salary is $630,370 per year as Pres, Chief Executive Officer & Director in Alimera Sciences, Inc..

How old is Richard S. Eiswirth Jr.?

Mr. Richard S. Eiswirth Jr. is 57 years old, born in 1968.

What stocks does Richard S. Eiswirth Jr. currently own?

As insider, Mr. Richard S. Eiswirth Jr. owns shares in one company:

Company Title Shares Price per share Total value
Alimera Sciences, Inc. (ALIM) Pres, Chief Executive Officer & Director 110,518 $0 $0

What does Alimera Sciences, Inc. do?

Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. The company sells its products to physician offices, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and sale of insert technology to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans or to treat diabetic macular edema. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia.

ALIM logo
ALIM
Alimera Sciences, Inc.

Richard S. Eiswirth Jr. insider trading

Alimera Sciences, Inc.

Mr. Richard S. Eiswirth Jr. has made 9 insider trades between 2010-2021, according to the Form 4 filled with the SEC. Most recently he purchased 484 units of ALIM stock worth $2,177 on 15 Dec 2021.

The largest trade he's ever made was exercising 100,000 units of ALIM stock on 14 Nov 2019. As of 15 Dec 2021 he still owns at least 110,518 units of ALIM stock.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 484 $4.5 $2,177
Purchase
Common Stock 5,000 $4.8 $23,980
Purchase
Common Stock 5,000 $4.89 $24,430
Purchase
Common Stock 1,400 $5.5 $7,700
Purchase
Common Stock 10,086 $4.41 $44,449
Purchase
Common Stock 28,005 $4.45 $124,734
Purchase
Common Stock 2,500 N/A N/A
Purchase
Common Stock 100,000 N/A N/A
Purchase
Common Stock 100,000 N/A N/A
Purchase
Common Stock 10,000 $1.05 $10,500
Sale
Common Stock 6,809 $1.18 $8,035
Sale
Common Stock 6,601 $1.22 $8,027
Sale
Common Stock 7,239 $1.23 $8,911
Sale
Common Stock 7,255 $1.24 $8,982
Sale
Common Stock 51,471 $1.33 $68,456
Option
Employee Stock Option (Right to Buy) 51,471 $1.33 $68,456
Option
Common Stock 51,471 $1.33 $68,456
Option
Employee Stock Option (Right to Buy) 15,409 $2.3 $35,394
Option
Common Stock 15,409 $2.3 $35,394
Sale
Common Stock 15,409 $2.3 $35,394
Sale
Common Stock 31,260 $1.33 $41,576
Option
Employee Stock Option (Right to Buy) 31,260 $1.33 $41,576
Option
Common Stock 31,260 $1.33 $41,576
Option
Common Stock 13,625 $2.04 $27,795
Option
Employee Stock Option (Right to Buy) 13,625 $2.04 $27,795
Sale
Common Stock 13,625 $2.04 $27,795
Purchase
Common Stock 10,000 $4.84 $48,400
Sale
Common Stock 50,000 $1.33 $66,500
Option
Employee Stock Option (Right to Buy) 50,000 $1.33 $66,500
Option
Common Stock 50,000 $1.33 $66,500
Purchase
Common Stock 5,000 $1.44 $7,220
Purchase
Common Stock 709 $9.14 $6,479
Purchase
Common Stock 300 $11.04 $3,311

Alimera Sciences key executives

Alimera Sciences, Inc. executives and other stock owners filed with the SEC:

  • Dr. Philip Ashman (60) Chief Operating Officer & Senior Vice President of Commercial Operations - Europe
  • Mr. Charles Daniel Myers (71) Non-Executive Chairman & Consultant
  • Mr. David R. Holland (61) Co-Founder, Chief Marketing Officer and Senior Vice President of Corporation Communications & Managed Markets
  • Mr. Richard S. Eiswirth Jr. (57) Pres, Chief Executive Officer & Director